Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Simpler antibiotics work just as well for complex kids with pneumonia. A new study in Pediatrics found that narrow-spectrum antibiotics like ampicillin and amoxicillin performed just as well as broad-spectrum drugs for hospitalized children with complex medical conditions and community-acquired pneumonia. No significant differences were found in hospital stay length, disease progression, or readmission rates — suggesting clinicians may not need to default to stronger drugs.
When it comes to treating pneumonia in medically complex kids, bigger isn't always better. A new observational study published in Pediatrics found that narrow-spectrum antibiotics — specifically ampicillin and amoxicillin — performed just as well as broad-spectrum alternatives like ceftriaxone for hospitalized children with complex chronic conditions and uncomplicated community-acquired pneumonia (CAP). This is notable because current guidelines from the Pediatric Infectious Diseases Society and IDSA simply don't cover this population, leaving clinicians to often default to broader drugs out of caution.
The study followed 749 children aged 3 months to 21 years treated at Children's Hospital of Philadelphia between 2016 and 2024. Researchers used statistical methods to make the two treatment groups comparable, accounting for the fact that children receiving broad-spectrum drugs were initially sicker.
Key Takeaways:
Why it matters: Medically complex children are frequently excluded from clinical research, leaving clinicians without solid evidence to guide antibiotic choices. This study challenges the assumption that complexity automatically warrants stronger antibiotics, potentially reducing unnecessary broad-spectrum use and the antimicrobial resistance risks that come with it.
